KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Moderna (MRNA) Change in Taxes (2021 - 2024)

Moderna (MRNA) has disclosed Change in Taxes for 4 consecutive years, with -$2.0 million as the latest value for Q3 2024.

  • Quarterly Change in Taxes fell 122.22% to -$2.0 million in Q3 2024 from the year-ago period, while the trailing twelve-month figure was -$51.0 million through Sep 2024, down 410.0% year-over-year, with the annual reading at $15.0 million for FY2023, 101.81% up from the prior year.
  • Change in Taxes for Q3 2024 was -$2.0 million at Moderna, up from -$45.0 million in the prior quarter.
  • The five-year high for Change in Taxes was $716.0 million in Q1 2022, with the low at -$1.2 billion in Q2 2022.
  • Average Change in Taxes over 4 years is $333333.3, with a median of $7.0 million recorded in 2023.
  • Peak annual rise in Change in Taxes hit 695.56% in 2022, while the deepest fall reached 533.1% in 2022.
  • Over 4 years, Change in Taxes stood at $311.0 million in 2021, then plummeted by 105.79% to -$18.0 million in 2022, then skyrocketed by 138.89% to $7.0 million in 2023, then tumbled by 128.57% to -$2.0 million in 2024.
  • According to Business Quant data, Change in Taxes over the past three periods came in at -$2.0 million, -$45.0 million, and -$11.0 million for Q3 2024, Q2 2024, and Q1 2024 respectively.